TrialBMC nephrology2026

Safety, pharmacokinetic, and pharmacodynamic characteristics of SK-08, a soluble guanylate cyclase activator, after oral administration in healthy participants: a randomized phase 1 trial.

Jian Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.